Women in STEM breaking barriers and advancing the future of regenerative medicine
Dr. Vasiliki E. Kalodimou on women in STEM, global collaboration and the next era of regenerative medicine
Dr. Vasiliki E. Kalodimou on women in STEM, global collaboration and the next era of regenerative medicine
Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people
Take the survey and submit a guest editorial
Authentic voices. Shared expertise. A global conversation advancing the future of diagnostics.
Discover how the HeadSMART II study is combining blood biomarkers, digital neurocognitive testing and AI to identify patients at risk of persistent TBI symptoms
New portfolio aims to support biosimilar developers accelerate the path to analytical similarity and improve process economics
Q&A with Microbiology in Health and Disease Lead Editor Liang Wang at the Journal of Applied Microbiology
Guest editorial written by Aida Noor, Biomedical Scientist, Founder of Biomedical Science & Beyond, CLINICAL24 Ambassador
Guest editorial by Maya Carlyle, Principal AI Engineer at the National Physical Laboratory (NPL)
Guest editorial by Frank Sandulu, award-winning Biomedical Scientist and CEO, Biomed Connect
Guest Editorial by Stephanie Ibbotson, Senior Director, Strategic Marketing and Market Access, Diasorin
Acquisition advances Leica Biosystems’ end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them
A new bench-top bioreactor platform with process control designed to support GMP-ready environments from 100 mL to 10 L working volume
Yale Professor Joe El-Khoury discusses Aletta, the ADOPT study and how autonomous blood collection could improve standardization, capacity, and quality across laboratory medicine
Irena Ivanova explores the potential of artificial intelligence to strengthen laboratory quality, efficiency and access to care while preserving human oversight and compassion
A validated bioassay that worked yesterday is not guaranteed to work tomorrow, and CRO Prolytix is urging the industry to rethink what ‘validated’ really means
Guest editorial by Russ Lebovitz, MD, PhD, is CEO and Co-Founder of Amprion
As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions
Uncover how ALS is readying its PFAS workflows for TFA and Europe's expanding surface and groundwater rules
Delivering reduced hands-on time, more consistent results, and higher sample throughput
PakScan brings configurable test layouts, low-headspace capability, and a smaller footprint to PACK EXPO International 2026
The non-invasive test could help clinicians identify women needing urgent hospital investigations while reassuring those unlikely to have womb cancer
Every cell biologist knows the feeling of staring at two identical experiments with different outcomes and wondering whether the answer lies in the biology or the handling
The two companies aim to strengthen disease awareness, support earlier assessment of the disease, and remove barriers to non-invasive testing